Literature DB >> 15338742

Topoisomerase II inhibitors.

Kenneth R Hande1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 15338742     DOI: 10.1016/s0921-4410(03)21005-x

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN: 0921-4410


× No keyword cloud information.
  4 in total

1.  Human multidrug resistance associated protein 4 confers resistance to camptothecins.

Authors:  Quan Tian; Jing Zhang; Theresa May Chin Tan; Eli Chan; Wei Duan; Sui Yung Chan; Urs Alex Boelsterli; Paul Chi-Lui Ho; Hongyuan Yang; Jin-Song Bian; Min Huang; Yi-Zhun Zhu; Weiping Xiong; Xiaotian Li; Shufeng Zhou
Journal:  Pharm Res       Date:  2005-11       Impact factor: 4.200

Review 2.  Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.

Authors:  Jörg T Hartmann; Hans-Peter Lipp
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides.

Authors:  Maria Duca; Dominique Guianvarc'h; Kahina Oussedik; Ludovic Halby; Anna Garbesi; Daniel Dauzonne; Claude Monneret; Neil Osheroff; Carine Giovannangeli; Paola B Arimondo
Journal:  Nucleic Acids Res       Date:  2006-04-05       Impact factor: 16.971

4.  Smoothed Potential MD Simulations for Dissociation Kinetics of Etoposide To Unravel Isoform Specificity in Targeting Human Topoisomerase II.

Authors:  Jissy A Kuriappan; Neil Osheroff; Marco De Vivo
Journal:  J Chem Inf Model       Date:  2019-09-09       Impact factor: 4.956

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.